Icon

AMVUTTRA (nda215515)- (EQ 25MG BASE/0.5ML (EQ 25MG BASE/0.5ML))

VUTRISIRAN SODIUM ALNYLAM PHARMS INC
EQ 25MG BASE/0.5ML (EQ 25MG BASE/0.5ML)
No No
2036-Jul-28 2027-Jun-13
None None
None No
AMVUTTRA is a transthyretin-directed small interfering RNA indicated for the treatment of the polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults.
0 0 0
Total Other Developers None
Drugs with Suitability No
EQ 25MG BASE/0.5ML (EQ 25MG BASE/0.5ML) ** ** - - -
NDA Sales Available Total Generic Sales Available
Yes 0
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country

GenUs Advanced Search




Expired
to
Expired
to


Please contact contact@researchdelta.com to get more details.